Cargando…
miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer
Neoadjuvant chemoradiotherapy (NCRT) followed by surgery is the gold standard for the treatment of patients with locally advanced rectal cancer (LARC). However, response is variable, and no predictive markers have been validated. The amplification of 13q31–34 seemed to distinguish between nonrespond...
Autores principales: | Molinari, Chiara, Salvi, Samanta, Foca, Flavia, Teodorani, Nazario, Saragoni, Luca, Puccetti, Maurizio, Passardi, Alessandro, Tamberi, Stefano, Avanzolini, Andrea, Lucci, Enrico, Calistri, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866748/ https://www.ncbi.nlm.nih.gov/pubmed/27226732 http://dx.doi.org/10.2147/OTT.S105760 |
Ejemplares similares
-
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011) -
miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster
por: Sweat, Yan, et al.
Publicado: (2021) -
Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
por: Xiang, Jie, et al.
Publicado: (2010) -
miR-17–92 cluster: ups and downs in cancer and aging
por: Grillari, Johannes, et al.
Publicado: (2010) -
Mir106b-25 and Mir17-92 Are Crucially Involved in the Development of Experimental Neuroinflammation
por: Finardi, Annamaria, et al.
Publicado: (2020)